- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01515930
Computerized Intervention of Parental Involvement in Diabetes Care of Their Child
June 1, 2017 updated by: Deborah Ellis, Ph.D., Wayne State University
Computer-Delivered Motivational Intervention to Improve Teen Diabetes Management
The purpose of this study is to develop an intervention to increase parental motivation for supervision and monitoring youth diabetes care behavior.
The intervention will be tested in three brief session in conjunction with regularly scheduled diabetes clinic visits and delivered through a computer program based in the principles of Motivational Interviewing.
Study Overview
Status
Completed
Conditions
Detailed Description
The study includes a development phase (Phase 1: development of the intervention followed by feasibility testing with 10 youth and 10 parents) and a pilot validation phase [Phase 2: pilot randomized clinical trial (RCT)] using a sample of 90 African American youth transitioning to independent diabetes care and their parents.
In this phase, families will be randomly assigned to one of three study arms: parent motivation for monitoring and youth motivation for diabetes care (arm 1), parent motivation for monitoring and youth information (arm 2) or parent and youth information (arm 3).
In phase 1 (development), youth and their caregivers will complete a one-time research visit where they use the program and provide feedback via a semi-structured interview regarding the usefulness of the content, its user-friendliness and make suggestions for changes to enhance acceptability.
In phase 2 ( RCT), families will complete three intervention plus data collection visits and one additional data collection only visit.
Research visits will be scheduled to coincide with appointments in the diabetes clinic to maximize convenience for families.
Study Type
Interventional
Enrollment (Actual)
145
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- Wayne State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 13 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- African American race/ethnicity
- Age: 10 years 0 months - 12 years, 11 months
- Type 1 diabetes mellitus
- Diagnosed at least 6 months
- Patient of Children's Hospital of Michigan Diabetes Clinics
- English fluency, both verbal and written
Exclusion Criteria:
- Psychiatry/psychological diagnoses including cognitive impairment that would prevent the participant from understanding the data collection measures, (i.e. moderate or severe mental retardation) or the following psychiatric diagnoses: autism and schizophrenia. Youth with current suicidal intent are not enrolled until psychiatrically stable.
- Medical diagnoses that would result in atypical diabetes management i.e. cystic fibrosis. Other medical conditions that would not affect diabetes management, such as asthma, do not exclude the participant from study participation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Active Caregiver and Active Child
Parent & Child Computer-Delivered Motivational Intervention will be delivered to participants.
A brief computer delivered behavior change counseling intervention for parents of children with diabetes to improve monitoring of diabetes care and a brief computer delivered behavior change counseling intervention for children with diabetes to improve completion of daily diabetes care.
|
Motivational Interviewing (MI) is a client-centered, directive method for enhancing intrinsic motivation to change by exploring & resolving ambivalence, with a strong evidence for improving adolescent & adult health behaviors.
Three motivational sessions will be provided by an animated character who delivers the intervention with high fidelity to MI principles.
Small amounts of psychoeducation about potential improvements illness management that can result from monitoring/completing diabetes care will be integrated with more purely motivational elements.
Mailings will be sent to participants to remind them of the reasons they gave as motivation & goals they set regarding diabetes care.
|
|
Experimental: Active Caregiver and Child Education
Parent Computer-Delivered Motivational Intervention will be delivered to the parents only.
A brief computer delivered behavior change counseling intervention for parents of children with diabetes to improve monitoring of diabetes care and a brief computer delivered informational session about diabetes related topics for their child with diabetes.
|
Motivational Interviewing (MI) is a client-centered, directive method for enhancing intrinsic motivation to change by exploring & resolving ambivalence, with a strong evidence for improving adolescent & adult health behaviors.
Three motivational sessions will be provided by an animated character who delivers the intervention with high fidelity to MI principles.
Small amounts of psychoeducation about potential improvements illness management that can result from parental monitoring of diabetes care will be integrated with more purely motivational elements.
Mailings will be sent to participants to remind them of the reasons they gave as motivation & goals they set regarding monitoring diabetes care.
|
|
Active Comparator: Education Caregiver/Education Child
Participants will receive computer-delivered information.
A brief computer delivered information session about diabetes related topics for both the caregiver and the child with diabetes.
|
Computer-Delivered Information about issues related to living with diabetes that do not directly impact completing diabetes care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diabetes Management Scale
Time Frame: Each of 3 intervention session, 3-4 month apart
|
The Diabetes Management Scale (DMS) (Frey, Ellis, Naar-King et al., 2004) is a self-report questionnaire used to measure a broad range of diabetes management behaviors, such as insulin management, dietary management, blood glucose monitoring, symptom response, and parent assistance/supervision.
|
Each of 3 intervention session, 3-4 month apart
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treatment Regulation Questionnaire
Time Frame: Each of 3 intervention session, 3-4 month apart
|
Parental motivation to monitor the youth is measured by the Treatment Self-Regulation Questionnaire (TSRQ; Ryan & Connell (1989).
The TSRQ evaluates why people engage in a health-relevant behavior and assesses the degree to which one's motivation for a particular behavior or set of behaviors is relatively autonomous or self-determined as compared to derived from external pressures or constraints.
|
Each of 3 intervention session, 3-4 month apart
|
|
Readiness Ruler
Time Frame: Each of 3 intervention session, 3-4 month apart
|
Parent motivation to monitor the youth is also measured by the Readiness Ruler (Stott, Rollnick, & Pill, 1995).
Since readiness to change behaviors is behavior specific, the items will be tailored to assess the behaviors most critical to parental monitoring of diabetes management.
The response format is a visual analog scale (VAS) 10 mm in length.
Written cues anchor the ends and middle of the scale.
Respondents mark their "readiness" on the scale and the position on the line is measured in millimeters.
|
Each of 3 intervention session, 3-4 month apart
|
|
HbA1C Blood Test
Time Frame: Each of 3 intervention session, 3-4 month apart
|
Metabolic control will be measured via hemoglobin A1c (HbA1c).
HbA1c is an indirect and retrospective measure of average blood glucose levels over the previous two to three month period.
|
Each of 3 intervention session, 3-4 month apart
|
|
Parental Monitoring of Diabetes Care
Time Frame: Each of 3 intervention session, 3-4 month apart
|
The Parental Monitoring of Diabetes Care scale (PMDC) is an 18 item, investigator-developed questionnaire that measures the frequency of parental monitoring and direct supervision of diabetes care tasks such as insulin administration, blood glucose testing, and dietary management.
|
Each of 3 intervention session, 3-4 month apart
|
|
Twenty-four Hour Recall Interview
Time Frame: Each of 3 intervention session, 3-4 month apart
|
The Twenty-four Hour Recall Interview, developed by Johnson and colleagues (Freund, Johnson, Silverstein et al., 1991), has been used extensively in pediatric diabetes research for the assessment of illness management.
|
Each of 3 intervention session, 3-4 month apart
|
|
Blood Glucose Testing Frequency
Time Frame: Each of 3 intervention session, 3-4 month apart
|
Objective data on mean daily frequency of blood glucose testing during the 14-day period prior to data collection will be obtained directly from blood glucose meters.
|
Each of 3 intervention session, 3-4 month apart
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Deborah A Ellis, Ph.D., Wayne State University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2011
Primary Completion (Actual)
March 3, 2014
Study Completion (Actual)
September 9, 2014
Study Registration Dates
First Submitted
January 18, 2012
First Submitted That Met QC Criteria
January 23, 2012
First Posted (Estimate)
January 24, 2012
Study Record Updates
Last Update Posted (Actual)
June 2, 2017
Last Update Submitted That Met QC Criteria
June 1, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3M's Diabetes Study
- R21DK089238 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of North Carolina, Chapel HillAmerican Diabetes AssociationNot yet recruitingType 2 Diabetes Mellitus (T2DM) | Diabetes (DM) | Insulin Dependent Diabetes | Type 1 Diabetes (T1D) | Diabetes Education | Diabetes Care | Diabetes (Insulin-requiring, Type 1 or Type 2)United States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Steno Diabetes Center CopenhagenNot yet recruitingDiabetes | Diabetes Type 1 | Diabetes Type 2 | Digital Health | Diabetes Care | Remote Patient MonitoringDenmark
Clinical Trials on Parent & Child Computer-Delivered Motivational Intervention
-
University of MichiganNational Institute on Drug Abuse (NIDA)Completed
-
Wayne State UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Ginger YangUniversity of Iowa; Ohio State University; University of NebraskaRecruitingCommunication | Recidivism | Drive | Feedback, PsychologicalUnited States
-
Karolinska InstitutetActive, not recruiting
-
Florida International UniversityBoston UniversityCompletedConduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder NosUnited States
-
Taipei Veterans General Hospital, TaiwanCompletedSleep Quality | Infant Health | Psychological HealthTaiwan
-
University of California, Los AngelesEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedChildren With AutismUnited States
-
University of Notre DameRecruitingMental Health | ConflictUnited States
-
Florida International UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedDevelopmental Delay | Disruptive BehaviorUnited States
-
Centers for Disease Control and PreventionCompleted